Taris Biomedical (US) Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 23

Employees

  • Latest Deal Type
  • M&A

Taris Biomedical (US) General Information

Description

Developer of targeted new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.

Contact Information

Formerly Known As
Certus Biomedical
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 113 Hartwell Avenue
  • Lexington, MA 02421
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Acquirer
Johnson & Johnson
Corporate Office
  • 113 Hartwell Avenue
  • Lexington, MA 02421
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Taris Biomedical (US) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 20-Dec-2019 Completed Generating Revenue
4. Later Stage VC (Series B) 21-Dec-2017 Completed Clinical Trials - Phase 2
3. Later Stage VC 27-Oct-2015 Completed Generating Revenue
2. Later Stage VC (Series B) 02-Apr-2013 $30.7M $45.7M Completed Generating Revenue
1. Early Stage VC (Series A) 24-Jun-2009 $15M $15M Completed Startup
To view Taris Biomedical (US)’s complete valuation and funding history, request access »

Taris Biomedical (US) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Taris Biomedical (US)’s complete cap table history, request access »

Taris Biomedical (US) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of targeted new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's sys
Drug Delivery
Lexington, MA
23 As of 2014

Debrecen, Hungary
 

Fort Lauderdale, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Taris Biomedical (US) Competitors (4)

One of Taris Biomedical (US)’s 4 competitors is BBS Nanotechnology, a Formerly VC-backed company based in Debrecen, Hungary.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BBS Nanotechnology Formerly VC-backed Debrecen, Hungary
NuView Life Sciences Accelerator/Incubator Backed Fort Lauderdale, FL
Cingulate Formerly VC-backed Kansas City, KS
Viatar CTC Solutions Formerly VC-backed Lowell, MA
To view Taris Biomedical (US)’s complete competitors history, request access »

Taris Biomedical (US) Patents

Taris Biomedical (US) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026058217-A1 Intravesical gemcitabine for use in treating bacillus calmette-guérin (bcg)-naive high-risk non-muscle invasive bladder cancer (hr-nmibc) Pending 13-Sep-2024
CA-233202-S Part of stylet for a urinary placement catheter Active 22-Mar-2024
CA-233200-S Stylet for a urinary placement catheter Active 22-Mar-2024
CA-233201-S Stylet for a urinary placement catheter Active 22-Mar-2024
WO-2025076007-A1 Methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guérin therapy Inactive 02-Oct-2023 A61K31/7068
To view Taris Biomedical (US)’s complete patent history, request access »

Taris Biomedical (US) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Taris Biomedical (US) Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bristol-Myers Squibb Corporation Minority
Flagship Pioneering Venture Capital Minority
Flybridge (New York) Venture Capital Minority
Foundation Medical Partners Corporate Venture Capital Minority
Norma Investments Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Taris Biomedical (US) FAQs

  • When was Taris Biomedical (US) founded?

    Taris Biomedical (US) was founded in 2008.

  • Where is Taris Biomedical (US) headquartered?

    Taris Biomedical (US) is headquartered in Lexington, MA.

  • What is the size of Taris Biomedical (US)?

    Taris Biomedical (US) has 23 total employees.

  • What industry is Taris Biomedical (US) in?

    Taris Biomedical (US)’s primary industry is Drug Delivery.

  • Is Taris Biomedical (US) a private or public company?

    Taris Biomedical (US) is a Private company.

  • What is Taris Biomedical (US)’s current revenue?

    The current revenue for Taris Biomedical (US) is .

  • How much funding has Taris Biomedical (US) raised over time?

    Taris Biomedical (US) has raised $103M.

  • Who are Taris Biomedical (US)’s investors?

    Bristol-Myers Squibb, Flagship Pioneering, Flybridge (New York), Foundation Medical Partners, and Norma Investments are 5 of 9 investors who have invested in Taris Biomedical (US).

  • Who are Taris Biomedical (US)’s competitors?

    BBS Nanotechnology, NuView Life Sciences, Cingulate, and Viatar CTC Solutions are competitors of Taris Biomedical (US).

  • When was Taris Biomedical (US) acquired?

    Taris Biomedical (US) was acquired on 20-Dec-2019.

  • Who acquired Taris Biomedical (US)?

    Taris Biomedical (US) was acquired by Johnson & Johnson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process